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The limits on protein detection in urine are unknown. Improving
the analytical approach to detection would increase the number of
identiﬁed proteins and potentially strengthen their predictive
potential in diseases.
Here, we present the data that resulted from a combination of
analytical procedures for maximizing sensitivity and reproducibility
of normal human urinary proteome analysis. These procedures are
ultracentrifugation, vesicle separation, combinatorial peptide ligand
libraries (CPLL) and solvent removal of pigments. Proteins were
identiﬁed by an Orbitrap Velos Mass Spectrometry. 3429 proteins
are characterized, 1724 of which are novel discoveries.
The data are related to Santucci et al. (in press) [1] and available
both here and at ChorusProject.org under project name “From hundreds
to thousands: widening the normal human Urinome”. The material
supplied to Chorus Progect.org includes technical MS spectra data only.
& 2014 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
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L. Santucci et al. / Data in Brief 1 (2014) 25–2826Speciﬁcations tableSubject area BiologyMore speciﬁc
subject area
C
w
haracterization of urine proteome in normal conditions. It was developed a new strategy of analysis
hich allowed the extension of the number of identiﬁed proteins to 3429 (1724 were of new
description here). The list of identiﬁed proteins is reported in Supplementary Table 1.
Type of data Excel tables
How data was
acquired
U
M
ltracentrifuge: Beckman OptimaTM l-90K (Ti 90 rotor).
ass spectroscopy: for analysis of all urinary sub-fractions was used a linear Trap Quadropole (LTQ)
Orbitrap Velos Pro Mass Spectrometry.
Data format Raw MS ﬁles as processed with the Thermo Scientiﬁc Proteome Discoverer software: peak were
searched by the MASCOT and SEQUEST against Uniprot human database, ﬁltered for a maximum 1%
FDR using Percolator; the Peptide Mass Deviation was set to 10 ppm and a minimum of six 6 amino
acids per identiﬁed peptide were required [2,3]. The Database search parameters were mass tolerance
precursor 20 ppm [4], mass tolerance fragment CID 0.8 Da with dynamic modiﬁcation of deamidation
(N, Q), oxidation (M) and static modiﬁcation of alkylation with IAM (C).
Label free experiments and statistical analysis were performed with Perseus software.Experimental factors Sample Collection and Urine Preparation: Second morning urine (approximately 160 mL) from healthy
volunteers were collected, centrifuged at 4 1C for 10 min at 1000g. Urine were frozen and maintained
at 80 until further processing [5–14]. Second step was centrifugation at 17,000g for 30 min at 16 1C.
The sample, after Bradford protein assay [15], was stored at 80 1C until use.Experimental
features
P
C
rocedure used for analysis of the urinary proteome: Vesicle Isolation, butanol precipitation,
ombinatorial Solid-Phase Ligand Library chromatography, Mass spectrometry and Bioinformatic
analysis.
Consent Informed consent was obtained from all the participants in the study.
Data source location Genova, Italy.
Data accessibility The data are available at ChorusProject.org under project name “From hundreds to thousands:
widening the normal human Urinome”. Row data relative to MS spectra are available
at ChorusProject.org under project name “From hundreds to thousands: widening the normal human
Urinome”. Data are also directly available with this articleValue of the data Sub-fractionating normal urine by successive steps allowed to identify 3429 proteins, a net þ50%
increment compared to traditional methods of analysis. Vesicles separation, CPLL and solvent treatments are the basic steps.
 1724 of the urine proteins identiﬁed here are of newly identiﬁed and described. Improved
characterization of the normal urinary proteome opens doors for the analysis of urine biomarkers
in human diseases.
1. Data, experimental design, materials and methods
3429 Non-redundant proteins discovered in our urine proteomic analysis are characterized and are
noted in Supplementary Table 1 [1]. 1615 of these proteins were contained in vesicles while the
remaining 1794 were equally distributed among CPLL (1488) and butanol insoluble fractions (322).
Several proteins were detected exclusively in one of the phases of the procedure, suggesting that each
step is crucial in the fractionation strategy. Many (1724) proteins are here described whose presence
in urine have never been reported and represent a potential source of information considering that
urine is the unique site of excretion of products of interaction of metabolic processes.
1.1. Urinary vesicles isolation
The 17,000g urinary supernatant (80 mL) was ultracentrifuged at 48,000 rpm for 75 min at 18 1C.
The ultracentrifugation step was repeated by adding the same volume used before until vesicles [16]
were isolated. The pellets, washed in DTT (200 mg/mL) and Tris–HCl 65 mM pH 8.8, was centrifuged a
14,000 rpm for 10 min at 4 1C and stored at 80 1C until mass spectrometry analysis.
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The 48,000 rpm supernatant was dialyzed versus water; aliquots of 50 mL were added with 100 mL
of acetic acid (about pH 3–4) and 10 mL of n-butanol and centrifuged at 4,000 rpm for 10 min at 18 1C.
Three different phases were obtained: protein pellet, supernatant (for ProteoMinerTM, see below) and
pigments (discarted), yielding two fractions: CPLL-beads chromatography and unbound.
1.2.1. Combinatorial peptide ligand library (CPLL)
The phase deriving from butanol extraction was lyophilized and loaded onto a column of 150 mL
peptide library beads equilibrated in 25 mM phosphate buffer, pH 7.4 as already described by
Candiano et al. [17,18]. The eluate and the unbound fraction were preserved at 80 1C until analysis
by mass spectrometry.
1.2.2. Mass spectrometry
Samples for mass spectrometry were solubilized in 0.1 mL of 4% SDS, 50 mM DTT, and 0.1 M Tris/
HCl, pH 7.6, at 90 1C for 5 min and brieﬂy sonicated and were processed by the FASP procedure using
30k Vivacom ﬁltration devices (Sartorius) [19].
The mass spectrometer LTQ-Orbitrap Velos Pro was operated in positive ionization mode.
Single MS survey scans were performed in the Orbitrap, recording a mass window between 350
and 1650 m/z using a maximal ion injection time of 250 ms. The resolution was set to 60,000 and the
automatic gain control was set to 1,000,000 ions. The experiments were done in data-dependent
acquisition mode with alternating MS and MS/MS experiments. A maximum of 10 MS/MS
experiments were triggered per MS scan.
Raw MS ﬁles were processed with Thermo Scientiﬁc Proteome Discoverer software version 1.3.
Peak list ﬁles were searched by the MASCOT and SEQUEST search engine against Uniprot human
database (Release 2012_07) containing both forward and reversed protein sequences. The Database
search parameters are mass tolerance precursor 20 ppm, mass tolerance fragment CID 0.8 Da and a
dynamic modiﬁcation of deamidation (N, Q), oxidation (M). For all searches the option trypsin with
two missed cleavages was selected. Proteins were grouped by applying the maximum parsimony rule.
Resulting peptide hits were ﬁltered for a maximum 1% FDR using Percolator and a Peptide Mass
Deviation of 10 ppm per identiﬁed peptide were required. To determine the area for any identiﬁed
peptides, we used precursor ions area detector node of Proteome Discoverer.
1.2.3. Bioinformatic analysis
All the statistical analyses of the identiﬁed protein tables were done with the Perseus program
(J. Cox, Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry,
Martinsried, Germany). For hierarchical clustering, we ﬁltered the data according to the technical
replicate and kept proteins with a minimum of 3 values repeated in the different analysis.
Logarithmized areas were z-scored and clustered using Euclidean distances between averages. Fisher
exact tests were done with a Benjamini–Hochberg FDR threshold of 0.02.Conﬂict of interest
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Supplementary data associated with this article can be found in the online version at http://dx.doi.
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